Showing results (701-710 of 792) with videos related to

Sort By:
Pageof 80
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2010
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndromeBrian L McClune, Daniel J Weisdorf, Tanya L Pedersen, et al.
Blood|April 21, 2010
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remissionDavid I Marks, Tao Wang, Waleska S Pérez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2010
Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adultsWillis H Navarro, Manza-A Agovi, Brent R Logan, et al.
Research Square|March 30, 2023
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American CollaborationTania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|February 21, 2025
Short-term and long-term management of caustic-induced gastrointestinal injury: An evidence-based practice guidelinesAnupam Kumar Singh, Deepak Gunjan, Nihar Ranjan Dash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2010
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failureMichel Duval, John P Klein, Wensheng He, et al.
Leukemia|December 19, 2023
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasmsTracy Murphy, Jacqueline M Mason, Brian Leber, et al.
Future Oncology (London, England)|January 11, 2021
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemicSrdan Verstovsek, Chih-Cheng Chen, Miklós Egyed, et al.
Frontiers in Plant Science|July 31, 2023
Virulence and genetic analysis of <i>Puccinia graminis tritici</i> in the Indian sub-continent from 2016 to 2022 and evaluation of wheat varieties for stem rust resistancePramod Prasad, Rajnikant Thakur, S C Bhardwaj, et al.
British Journal of Haematology|February 5, 2020
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet countsHaifa Kathrin Al-Ali, Martin Griesshammer, Lynda Foltz, et al.
Pageof 80